RecruitingNot applicableNCT06959251

Glycine and Magnesium+Thiamine for the Treatment of Primary Ciliary Dyskinesia

Studying Primary ciliary dyskinesia

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Instituto Nacional de Enfermedades Respiratorias
Principal Investigator
Mario H. Vargas, MSc
5556665868
Intervention
Glycine(dietary_supplement)
Enrollment
60 enrolled
Eligibility
5 years · All sexes
Timeline
20252028

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06959251 on ClinicalTrials.gov

Other trials for Primary ciliary dyskinesia

Additional recruiting or active studies for the same condition.

See all trials for Primary ciliary dyskinesia

← Back to all trials